Chinese General Practice ›› 2022, Vol. 25 ›› Issue (09): 1098-1104.DOI: 10.12114/j.issn.1007-9572.2021.02.074
• Article • Previous Articles Next Articles
Probability of Premature Mortality Caused by Major Non-communicable Diseases in Pudong New Area of Shanghai,2002—2020
Shanghai Pudong New Area Center for Disease Control and Prevention,Fudan University Pudong Institute of Preventive Medicine,Shanghai 200136,China
*Corresponding author:ZHOU Yi,Associate chief physician;E-mail:yizhou517@163.com
Received:
2021-05-28
Revised:
2021-09-28
Published:
2022-03-20
Online:
2022-03-01
通讯作者:
周弋
基金资助:
CLC Number:
CHEN Yichen, CHEN Hua, ZHOU Yi, QU Xiaobing, SUN Lianghong, CHEN Hanyi, LI Xiaopan, YANG Chen, XIAO Shaotan.
Probability of Premature Mortality Caused by Major Non-communicable Diseases in Pudong New Area of Shanghai,2002—2020 [J]. Chinese General Practice, 2022, 25(09): 1098-1104.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.074
时间(年) | 合计 | 男性 | 女性 | |||
---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 526.82 | 404.05 | 567.44 | 475.44 | 486.23 | 345.62 |
2003 | 551.87 | 403.15 | 586.44 | 464.29 | 517.23 | 353.09 |
2004 | 523.01 | 339.30 | 563.07 | 392.09 | 482.77 | 293.35 |
2005 | 561.34 | 353.24 | 609.02 | 411.22 | 513.41 | 302.23 |
2006 | 530.73 | 333.30 | 584.73 | 393.19 | 476.47 | 280.15 |
2007 | 548.57 | 331.27 | 599.47 | 387.71 | 497.50 | 281.17 |
2008 | 562.57 | 321.05 | 605.26 | 369.43 | 519.84 | 277.67 |
2009 | 558.12 | 310.18 | 608.86 | 359.74 | 507.46 | 264.49 |
2010 | 561.81 | 300.35 | 612.74 | 347.76 | 511.05 | 256.12 |
2011 | 584.24 | 303.05 | 641.16 | 351.16 | 527.60 | 257.71 |
2012 | 616.03 | 306.56 | 671.85 | 354.37 | 560.53 | 260.96 |
2013 | 603.96 | 290.88 | 656.52 | 336.60 | 551.69 | 246.28 |
2014 | 621.46 | 288.29 | 680.92 | 333.07 | 562.31 | 244.31 |
2015 | 660.88 | 295.76 | 724.02 | 340.53 | 598.07 | 251.26 |
2016 | 651.72 | 282.50 | 710.19 | 324.48 | 593.56 | 240.32 |
2017 | 660.10 | 277.69 | 718.84 | 317.47 | 601.71 | 237.61 |
2018 | 656.15 | 269.06 | 726.44 | 312.47 | 586.36 | 224.62 |
2019 | 676.91 | 265.75 | 754.59 | 311.23 | 599.91 | 218.96 |
2020 | 678.84 | 260.87 | 741.21 | 299.60 | 617.11 | 220.66 |
合计 | 600.29 | 305.96 | 654.93 | 353.67 | 545.81 | 260.59 |
APC(%) | 1.56 | -2.09 | 1.68 | -2.15 | 1.41 | -2.24 |
Z值 | 13.715 | -12.428 | 16.286 | -12.709 | 10.307 | -12.300 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 The trend analysis of the mortality of four major non-communicable diseases among male and female populations in Pudong New Area of Shanghai,2002—2020
时间(年) | 合计 | 男性 | 女性 | |||
---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 526.82 | 404.05 | 567.44 | 475.44 | 486.23 | 345.62 |
2003 | 551.87 | 403.15 | 586.44 | 464.29 | 517.23 | 353.09 |
2004 | 523.01 | 339.30 | 563.07 | 392.09 | 482.77 | 293.35 |
2005 | 561.34 | 353.24 | 609.02 | 411.22 | 513.41 | 302.23 |
2006 | 530.73 | 333.30 | 584.73 | 393.19 | 476.47 | 280.15 |
2007 | 548.57 | 331.27 | 599.47 | 387.71 | 497.50 | 281.17 |
2008 | 562.57 | 321.05 | 605.26 | 369.43 | 519.84 | 277.67 |
2009 | 558.12 | 310.18 | 608.86 | 359.74 | 507.46 | 264.49 |
2010 | 561.81 | 300.35 | 612.74 | 347.76 | 511.05 | 256.12 |
2011 | 584.24 | 303.05 | 641.16 | 351.16 | 527.60 | 257.71 |
2012 | 616.03 | 306.56 | 671.85 | 354.37 | 560.53 | 260.96 |
2013 | 603.96 | 290.88 | 656.52 | 336.60 | 551.69 | 246.28 |
2014 | 621.46 | 288.29 | 680.92 | 333.07 | 562.31 | 244.31 |
2015 | 660.88 | 295.76 | 724.02 | 340.53 | 598.07 | 251.26 |
2016 | 651.72 | 282.50 | 710.19 | 324.48 | 593.56 | 240.32 |
2017 | 660.10 | 277.69 | 718.84 | 317.47 | 601.71 | 237.61 |
2018 | 656.15 | 269.06 | 726.44 | 312.47 | 586.36 | 224.62 |
2019 | 676.91 | 265.75 | 754.59 | 311.23 | 599.91 | 218.96 |
2020 | 678.84 | 260.87 | 741.21 | 299.60 | 617.11 | 220.66 |
合计 | 600.29 | 305.96 | 654.93 | 353.67 | 545.81 | 260.59 |
APC(%) | 1.56 | -2.09 | 1.68 | -2.15 | 1.41 | -2.24 |
Z值 | 13.715 | -12.428 | 16.286 | -12.709 | 10.307 | -12.300 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
时间(年) | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 210.37 | 156.71 | 202.28 | 163.15 | 19.63 | 14.87 | 94.54 | 69.32 |
2003 | 218.87 | 154.67 | 212.57 | 164.43 | 25.25 | 18.32 | 95.18 | 65.73 |
2004 | 212.37 | 130.90 | 207.28 | 145.36 | 24.65 | 15.79 | 78.71 | 47.26 |
2005 | 233.73 | 139.16 | 217.21 | 148.93 | 25.06 | 15.54 | 85.33 | 49.61 |
2006 | 217.65 | 129.05 | 215.83 | 146.78 | 25.61 | 16.20 | 71.65 | 41.27 |
2007 | 231.19 | 131.37 | 214.61 | 141.81 | 26.06 | 15.70 | 76.71 | 42.40 |
2008 | 243.68 | 129.86 | 215.47 | 136.53 | 25.47 | 14.49 | 77.95 | 40.17 |
2009 | 238.50 | 123.30 | 223.93 | 138.06 | 27.29 | 15.03 | 68.41 | 33.78 |
2010 | 242.66 | 119.41 | 227.19 | 136.13 | 27.33 | 14.41 | 64.63 | 30.40 |
2011 | 249.71 | 118.28 | 234.55 | 137.16 | 29.48 | 15.38 | 70.50 | 32.23 |
2012 | 275.75 | 124.84 | 234.47 | 133.53 | 31.84 | 16.08 | 73.98 | 32.12 |
2013 | 268.57 | 116.60 | 238.02 | 131.08 | 32.93 | 15.97 | 64.44 | 27.23 |
2014 | 279.12 | 117.58 | 238.15 | 127.41 | 34.67 | 15.88 | 69.52 | 27.43 |
2015 | 300.87 | 120.29 | 246.56 | 128.87 | 39.08 | 17.80 | 74.37 | 28.79 |
2016 | 301.54 | 116.97 | 242.73 | 122.80 | 40.16 | 17.62 | 67.29 | 25.10 |
2017 | 304.89 | 113.89 | 244.59 | 121.16 | 44.07 | 18.55 | 66.55 | 24.10 |
2018 | 310.12 | 113.54 | 239.85 | 115.90 | 42.17 | 17.38 | 64.00 | 22.24 |
2019 | 321.27 | 111.44 | 245.51 | 114.32 | 47.05 | 18.60 | 63.08 | 21.38 |
2020 | 335.36 | 114.27 | 246.62 | 112.66 | 45.50 | 17.10 | 51.36 | 16.84 |
合计 | 265.75 | 123.61 | 229.82 | 133.22 | 32.85 | 16.61 | 71.87 | 32.52 |
APC(%) | 22.66 | -1.54 | 1.11 | -1.85 | 4.49 | 0.80 | -2.17 | -6.27 |
Z值 | 20.455 | -8.092 | 13.482 | -17.693 | 16.768 | 2.685 | -6.451 | -16.276 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.016 | <0.001 | <0.001 |
Table 2 The trend analysis of the mortality of four major non-communicable diseases among residents in Pudong New Area of Shanghai,2002—2020
时间(年) | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 210.37 | 156.71 | 202.28 | 163.15 | 19.63 | 14.87 | 94.54 | 69.32 |
2003 | 218.87 | 154.67 | 212.57 | 164.43 | 25.25 | 18.32 | 95.18 | 65.73 |
2004 | 212.37 | 130.90 | 207.28 | 145.36 | 24.65 | 15.79 | 78.71 | 47.26 |
2005 | 233.73 | 139.16 | 217.21 | 148.93 | 25.06 | 15.54 | 85.33 | 49.61 |
2006 | 217.65 | 129.05 | 215.83 | 146.78 | 25.61 | 16.20 | 71.65 | 41.27 |
2007 | 231.19 | 131.37 | 214.61 | 141.81 | 26.06 | 15.70 | 76.71 | 42.40 |
2008 | 243.68 | 129.86 | 215.47 | 136.53 | 25.47 | 14.49 | 77.95 | 40.17 |
2009 | 238.50 | 123.30 | 223.93 | 138.06 | 27.29 | 15.03 | 68.41 | 33.78 |
2010 | 242.66 | 119.41 | 227.19 | 136.13 | 27.33 | 14.41 | 64.63 | 30.40 |
2011 | 249.71 | 118.28 | 234.55 | 137.16 | 29.48 | 15.38 | 70.50 | 32.23 |
2012 | 275.75 | 124.84 | 234.47 | 133.53 | 31.84 | 16.08 | 73.98 | 32.12 |
2013 | 268.57 | 116.60 | 238.02 | 131.08 | 32.93 | 15.97 | 64.44 | 27.23 |
2014 | 279.12 | 117.58 | 238.15 | 127.41 | 34.67 | 15.88 | 69.52 | 27.43 |
2015 | 300.87 | 120.29 | 246.56 | 128.87 | 39.08 | 17.80 | 74.37 | 28.79 |
2016 | 301.54 | 116.97 | 242.73 | 122.80 | 40.16 | 17.62 | 67.29 | 25.10 |
2017 | 304.89 | 113.89 | 244.59 | 121.16 | 44.07 | 18.55 | 66.55 | 24.10 |
2018 | 310.12 | 113.54 | 239.85 | 115.90 | 42.17 | 17.38 | 64.00 | 22.24 |
2019 | 321.27 | 111.44 | 245.51 | 114.32 | 47.05 | 18.60 | 63.08 | 21.38 |
2020 | 335.36 | 114.27 | 246.62 | 112.66 | 45.50 | 17.10 | 51.36 | 16.84 |
合计 | 265.75 | 123.61 | 229.82 | 133.22 | 32.85 | 16.61 | 71.87 | 32.52 |
APC(%) | 22.66 | -1.54 | 1.11 | -1.85 | 4.49 | 0.80 | -2.17 | -6.27 |
Z值 | 20.455 | -8.092 | 13.482 | -17.693 | 16.768 | 2.685 | -6.451 | -16.276 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.016 | <0.001 | <0.001 |
时间(年) | 4类主要慢性病 | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | |
2002 | 13.09 | 16.79 | 9.41 | 3.57 | 4.36 | 2.80 | 8.36 | 11.10 | 5.66 | 0.57 | 0.53 | 0.61 | 1.08 | 1.61 | 0.59 |
2003 | 13.39 | 16.80 | 9.97 | 3.64 | 4.50 | 2.80 | 8.55 | 11.00 | 6.11 | 0.61 | 0.59 | 0.62 | 1.12 | 1.52 | 0.73 |
2004 | 11.66 | 14.66 | 8.59 | 3.10 | 3.87 | 2.34 | 7.59 | 9.71 | 5.44 | 0.57 | 0.55 | 0.57 | 0.78 | 1.13 | 0.45 |
2005 | 11.93 | 15.16 | 8.56 | 3.30 | 4.13 | 2.44 | 7.66 | 9.98 | 5.28 | 0.49 | 0.45 | 0.53 | 0.88 | 1.25 | 0.53 |
2006 | 11.25 | 14.53 | 7.83 | 2.88 | 3.75 | 1.99 | 7.49 | 9.80 | 5.10 | 0.60 | 0.67 | 0.52 | 0.63 | 0.87 | 0.39 |
2007 | 10.76 | 13.91 | 7.46 | 2.91 | 3.92 | 1.88 | 7.00 | 9.08 | 4.84 | 0.47 | 0.47 | 0.47 | 0.70 | 0.98 | 0.42 |
2008 | 10.30 | 12.93 | 7.54 | 2.73 | 3.50 | 1.94 | 6.79 | 8.65 | 4.87 | 0.48 | 0.51 | 0.44 | 0.58 | 0.72 | 0.44 |
2009 | 10.49 | 13.45 | 7.35 | 2.86 | 3.93 | 1.76 | 6.92 | 8.75 | 5.02 | 0.50 | 0.59 | 0.42 | 0.50 | 0.70 | 0.29 |
2010 | 10.06 | 13.04 | 6.91 | 2.60 | 3.42 | 1.75 | 6.83 | 8.93 | 4.63 | 0.48 | 0.51 | 0.45 | 0.42 | 0.63 | 0.20 |
2011 | 9.85 | 12.74 | 6.79 | 2.54 | 3.65 | 1.40 | 6.61 | 8.34 | 4.81 | 0.53 | 0.63 | 0.42 | 0.42 | 0.57 | 0.27 |
2012 | 9.76 | 12.78 | 6.56 | 2.58 | 3.52 | 1.61 | 6.52 | 8.41 | 4.54 | 0.48 | 0.63 | 0.32 | 0.44 | 0.67 | 0.20 |
2013 | 9.55 | 12.69 | 6.25 | 2.46 | 3.49 | 1.40 | 6.39 | 8.31 | 4.40 | 0.45 | 0.57 | 0.33 | 0.49 | 0.77 | 0.21 |
2014 | 9.35 | 12.51 | 6.03 | 2.54 | 3.66 | 1.38 | 6.18 | 8.09 | 4.21 | 0.49 | 0.64 | 0.34 | 0.37 | 0.55 | 0.19 |
2015 | 9.51 | 12.66 | 6.21 | 2.46 | 3.58 | 1.32 | 6.32 | 8.18 | 4.41 | 0.53 | 0.75 | 0.31 | 0.43 | 0.59 | 0.27 |
2016 | 9.23 | 12.21 | 6.11 | 2.44 | 3.47 | 1.38 | 6.13 | 7.96 | 4.24 | 0.57 | 0.74 | 0.41 | 0.31 | 0.45 | 0.18 |
2017 | 8.89 | 11.96 | 5.70 | 2.48 | 3.70 | 1.24 | 5.73 | 7.41 | 4.01 | 0.56 | 0.76 | 0.36 | 0.34 | 0.50 | 0.17 |
2018 | 8.83 | 11.91 | 5.65 | 2.41 | 3.62 | 1.18 | 5.74 | 7.44 | 4.01 | 0.55 | 0.73 | 0.36 | 0.35 | 0.53 | 0.17 |
2019 | 8.47 | 11.61 | 5.25 | 2.33 | 3.46 | 1.19 | 5.51 | 7.31 | 3.68 | 0.55 | 0.76 | 0.34 | 0.28 | 0.47 | 0.10 |
2020 | 8.45 | 11.48 | 5.35 | 2.38 | 3.57 | 1.19 | 5.49 | 7.13 | 3.85 | 0.53 | 0.77 | 0.29 | 0.24 | 0.39 | 0.09 |
合计 | 9.93 | 13.02 | 6.70 | 2.63 | 3.66 | 1.60 | 6.56 | 8.51 | 4.55 | 0.52 | 0.64 | 0.40 | 0.48 | 0.69 | 0.27 |
APC(%) | -2.31 | -1.87 | -3.21 | -2.21 | -1.02 | -4.83 | -2.24 | -2.21 | -2.31 | -0.15 | 2.43 | -3.70 | -7.23 | -6.59 | -9.24 |
Z值 | -15.847 | -11.270 | -20.202 | -9.739 | -4.432 | -15.527 | -19.476 | -15.799 | -15.960 | -0.395 | 5.194 | -8.502 | -13.326 | -10.606 | -11.565 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.698 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 3 The trend analysis of probability of premature mortality caused by four major non-communicable diseases among residents in Pudong New Area of Shanghai,2002—2020
时间(年) | 4类主要慢性病 | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | |
2002 | 13.09 | 16.79 | 9.41 | 3.57 | 4.36 | 2.80 | 8.36 | 11.10 | 5.66 | 0.57 | 0.53 | 0.61 | 1.08 | 1.61 | 0.59 |
2003 | 13.39 | 16.80 | 9.97 | 3.64 | 4.50 | 2.80 | 8.55 | 11.00 | 6.11 | 0.61 | 0.59 | 0.62 | 1.12 | 1.52 | 0.73 |
2004 | 11.66 | 14.66 | 8.59 | 3.10 | 3.87 | 2.34 | 7.59 | 9.71 | 5.44 | 0.57 | 0.55 | 0.57 | 0.78 | 1.13 | 0.45 |
2005 | 11.93 | 15.16 | 8.56 | 3.30 | 4.13 | 2.44 | 7.66 | 9.98 | 5.28 | 0.49 | 0.45 | 0.53 | 0.88 | 1.25 | 0.53 |
2006 | 11.25 | 14.53 | 7.83 | 2.88 | 3.75 | 1.99 | 7.49 | 9.80 | 5.10 | 0.60 | 0.67 | 0.52 | 0.63 | 0.87 | 0.39 |
2007 | 10.76 | 13.91 | 7.46 | 2.91 | 3.92 | 1.88 | 7.00 | 9.08 | 4.84 | 0.47 | 0.47 | 0.47 | 0.70 | 0.98 | 0.42 |
2008 | 10.30 | 12.93 | 7.54 | 2.73 | 3.50 | 1.94 | 6.79 | 8.65 | 4.87 | 0.48 | 0.51 | 0.44 | 0.58 | 0.72 | 0.44 |
2009 | 10.49 | 13.45 | 7.35 | 2.86 | 3.93 | 1.76 | 6.92 | 8.75 | 5.02 | 0.50 | 0.59 | 0.42 | 0.50 | 0.70 | 0.29 |
2010 | 10.06 | 13.04 | 6.91 | 2.60 | 3.42 | 1.75 | 6.83 | 8.93 | 4.63 | 0.48 | 0.51 | 0.45 | 0.42 | 0.63 | 0.20 |
2011 | 9.85 | 12.74 | 6.79 | 2.54 | 3.65 | 1.40 | 6.61 | 8.34 | 4.81 | 0.53 | 0.63 | 0.42 | 0.42 | 0.57 | 0.27 |
2012 | 9.76 | 12.78 | 6.56 | 2.58 | 3.52 | 1.61 | 6.52 | 8.41 | 4.54 | 0.48 | 0.63 | 0.32 | 0.44 | 0.67 | 0.20 |
2013 | 9.55 | 12.69 | 6.25 | 2.46 | 3.49 | 1.40 | 6.39 | 8.31 | 4.40 | 0.45 | 0.57 | 0.33 | 0.49 | 0.77 | 0.21 |
2014 | 9.35 | 12.51 | 6.03 | 2.54 | 3.66 | 1.38 | 6.18 | 8.09 | 4.21 | 0.49 | 0.64 | 0.34 | 0.37 | 0.55 | 0.19 |
2015 | 9.51 | 12.66 | 6.21 | 2.46 | 3.58 | 1.32 | 6.32 | 8.18 | 4.41 | 0.53 | 0.75 | 0.31 | 0.43 | 0.59 | 0.27 |
2016 | 9.23 | 12.21 | 6.11 | 2.44 | 3.47 | 1.38 | 6.13 | 7.96 | 4.24 | 0.57 | 0.74 | 0.41 | 0.31 | 0.45 | 0.18 |
2017 | 8.89 | 11.96 | 5.70 | 2.48 | 3.70 | 1.24 | 5.73 | 7.41 | 4.01 | 0.56 | 0.76 | 0.36 | 0.34 | 0.50 | 0.17 |
2018 | 8.83 | 11.91 | 5.65 | 2.41 | 3.62 | 1.18 | 5.74 | 7.44 | 4.01 | 0.55 | 0.73 | 0.36 | 0.35 | 0.53 | 0.17 |
2019 | 8.47 | 11.61 | 5.25 | 2.33 | 3.46 | 1.19 | 5.51 | 7.31 | 3.68 | 0.55 | 0.76 | 0.34 | 0.28 | 0.47 | 0.10 |
2020 | 8.45 | 11.48 | 5.35 | 2.38 | 3.57 | 1.19 | 5.49 | 7.13 | 3.85 | 0.53 | 0.77 | 0.29 | 0.24 | 0.39 | 0.09 |
合计 | 9.93 | 13.02 | 6.70 | 2.63 | 3.66 | 1.60 | 6.56 | 8.51 | 4.55 | 0.52 | 0.64 | 0.40 | 0.48 | 0.69 | 0.27 |
APC(%) | -2.31 | -1.87 | -3.21 | -2.21 | -1.02 | -4.83 | -2.24 | -2.21 | -2.31 | -0.15 | 2.43 | -3.70 | -7.23 | -6.59 | -9.24 |
Z值 | -15.847 | -11.270 | -20.202 | -9.739 | -4.432 | -15.527 | -19.476 | -15.799 | -15.960 | -0.395 | 5.194 | -8.502 | -13.326 | -10.606 | -11.565 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.698 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
类别 | 2015年早死概率 | 2020年早死概率 | 2030年预期早死概率 | 年均增长率 | 2020年目标 | 2030年目标 | |
---|---|---|---|---|---|---|---|
全人群 | 9.51 | 8.45 | 6.67 | -2.33 | 8.56 | 6.66 | |
性别分类 | |||||||
男性 | 12.66 | 11.48 | 9.44 | -1.94 | 11.39 | 8.86 | |
女性 | 6.21 | 5.35 | 3.98 | -2.93 | 5.59 | 4.35 | |
病种分类 | |||||||
心脑血管疾病 | 2.46 | 2.38 | 2.23 | -0.66 | 2.22 | 1.72 | |
恶性肿瘤 | 6.32 | 5.49 | 4.14 | -2.78 | 5.69 | 4.43 | |
糖尿病 | 0.53 | 0.53 | 0.52 | -0.20 | 0.48 | 0.37 | |
慢性呼吸系统疾病 | 0.43 | 0.24 | 0.07 | -11.05 | 0.38 | 0.30 |
Table 4 The analysis ofthetarget in Health China 2030 plan of reducing the probability of premature mortalitycaused by four major non-communicable diseases in Pudong New Area of Shanghai
类别 | 2015年早死概率 | 2020年早死概率 | 2030年预期早死概率 | 年均增长率 | 2020年目标 | 2030年目标 | |
---|---|---|---|---|---|---|---|
全人群 | 9.51 | 8.45 | 6.67 | -2.33 | 8.56 | 6.66 | |
性别分类 | |||||||
男性 | 12.66 | 11.48 | 9.44 | -1.94 | 11.39 | 8.86 | |
女性 | 6.21 | 5.35 | 3.98 | -2.93 | 5.59 | 4.35 | |
病种分类 | |||||||
心脑血管疾病 | 2.46 | 2.38 | 2.23 | -0.66 | 2.22 | 1.72 | |
恶性肿瘤 | 6.32 | 5.49 | 4.14 | -2.78 | 5.69 | 4.43 | |
糖尿病 | 0.53 | 0.53 | 0.52 | -0.20 | 0.48 | 0.37 | |
慢性呼吸系统疾病 | 0.43 | 0.24 | 0.07 | -11.05 | 0.38 | 0.30 |
[1] | World Health Organization. World Health Statistics 2020[EB/OL]. [2021-05-02].. |
[2] | World Health Organization. Global Health Estimates 2016:Deaths by Cause,Age,Sex,by Country and by Region,2000—2016. [EB/OL]. [2021-05-02].. |
[3] | TAN X D,ZHANG Y N,SHAO H Y. Healthy China 2030,a breakthrough for improving health[J]. Glob Health Promot,2019,26(4):96-99. DOI:10.1177/1757975917743533. |
[4] | LUO Z,LV H,CHEN Y C,et al. Years of life lost due to premature death and their trends in people with selected neurological disorders in Shanghai,China,1995—2018:a population-based study[J]. Front Neurol,2021,12:625042. DOI:10.3389/fneur.2021.625042. |
[5] | World Health Organization. Global status report on noncommunicable diseases 2014[M]. Geneva:World Health Organization,2014. |
[6] | 曾新颖,李镒冲,刘世炜,等. 1990—2015年中国四类慢性病早死概率与"健康中国2030"下降目标分析[J]. 中华预防医学杂志,2017,51(3):209-214. DOI:10.3760/cma.j.issn.0253-9624.2017.03.004. |
[7] | ZHOU M G,WANG H D,ZHU J,et al. Cause-specific mortality for 240 causes in China during 1990—2013:a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet,2016,387(10015):251-272. DOI:10.1016/S0140-6736(15)00551-6. |
[8] | 丁贤彬,许杰,焦艳,等. 2015—2019年重庆市主要慢性病早死概率与"健康中国2030"下降目标分析[J]. 中国慢性病预防与控制,2020,28(8):574-577. DOI:10.16386/j.cjpccd.issn.1004-6194.2020.08.005. |
[9] | 杨梨丽,林启,王玉超,等. 2009—2018年舟山市4类主要慢性病早死概率及"健康中国2030"目标分析[J]. 中国慢性病预防与控制,2021,29(2):140-143. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.02.014. |
[10] | 王淼,范美娟. 2006—2019年天津市河西区主要慢性病死亡情况及早死概率趋势分析[J]. 中国慢性病预防与控制,2021,29(1):77-80. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.01.018. |
[11] | 刘天娥,胡永勤,唐爱奇,等. 2010—2018年杭州市余杭区主要慢性病死亡及早死趋势分析[J]. 中国慢性病预防与控制,2020,28(11):878-881. DOI:10.16386/j.cjpccd.issn.1004-6194.2020.11.019. |
[12] | 王联君,周莹,李茜瑶,等. 2007—2018年北京市东城区主要慢性病死亡状况及过早死亡分析[J]. 现代预防医学,2020,47(4):626-630. |
[13] | 朱晓云,张亚宁,马碧萍. 2002—2017年上海市金山区慢性非传染性疾病死亡水平及其所致过早死亡风险分析[J]. 中国预防医学杂志,2019,20(10):966-971. DOI:10.16506/j.1009-6639.2019.10.017. |
[14] | 苏玉,杨益联,徐美娟,等. 2010—2019年天津市东丽区主要慢性病过早死亡趋势分析[J]. 中国慢性病预防与控制,2021,29(3):233-236. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.03.018. |
[15] | 丁贤彬,唐文革,焦艳,等. 2010—2016年重庆市4种主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2017,25(9):641-645. DOI:10.16386/j.cjpccd.issn.1004-6194.2017.09.001. |
[16] | 国务院办公厅.国务院办公厅关于印发中国防治慢性病中长期规划(2017—2025年)的通知 [EB/OL]. (2017-02-14)[2021-05-02].. |
[17] | 董航,李燕,林国桢,等. 2010—2017年广州市重大慢性非传染性疾病早死概率变化趋势分析[J]. 中国慢性病预防与控制,2019,27(6):472-474. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.06.019. |
[18] | 徐红,黄玮奕. 2005—2018年南通市4类慢性病早死概率及其变化趋势[J]. 中国慢性病预防与控制,2021,29(4):314-317. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.04.018. |
[19] | 王璐,陈海,钱云,等.无锡市2008-2018年主要慢性病过早死亡对期望寿命的影响[J].中华流行病学杂志,2021,42(2):291-296.DOI:10.3760/cma.j.cn112338-20200403-00506. |
[20] | 徐继英,李新建,姚海宏,等. 上海市成年人慢性病相关危险因素行为特征研究[J]. 中华预防医学杂志,2013,47(9):821-825. DOI:10.3760/cma.j.issn.0253-9624.2013.09.011. |
[21] | 王德征,张辉,徐忠良,等.天津市1999—2015年慢性非传染性疾病过早死亡趋势分析[J].中华流行病学杂志,2017,38(12):1672-1676.DOI:10.3760/cma.j.issn.0254-6450.2017.12.018. |
[22] | 邢秀雅,贺琴,程倩瑶,等.安徽省2014—2018年4类重大慢性病早死概率变化趋势及健康指标达标分析[J].中华流行病学杂志,2021,42(3):531-537.DOI:10.3760/cma.j.cn112338-20200319-00391. |
[23] | ZHOU M G,ASTELL-BURT T,BI Y F,et al. Geographical variation in diabetes prevalence and detection in China:multilevel spatial analysis of 98,058 adults[J]. Diabetes Care,2015,38(1):72-81. DOI:10.2337/dc14-1100. |
[24] | RUAN Y,YAN Q H,XU J Y,et al. Epidemiology of diabetes in adults aged 35 and older from Shanghai,China[J]. Biomed Environ Sci,2016,29(6):408-416. DOI:10.3967/bes2016.053. |
[25] | CHEN H Y,HAO L P,YANG C,et al. Understanding the rapid increase in life expectancy in Shanghai,China:a population-based retrospective analysis[J]. BMC Public Health,2018,18(1):256. DOI:10.1186/s12889-018-5112-7. |
[26] | 丁贤彬,唐文革,毛德强,等. 慢性病综合防控示范区建设对主要慢性病早死概率的影响[J]. 中国慢性病预防与控制,2018,26(1):1-4. DOI:10.16386/j.cjpccd.issn.1004-6194.2018.01.001. |
[1] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[2] | LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307. |
[3] | ZHU Wenpeng, HAN Mengqi, WANG Yuxin, WANG Guoping. Trends and Projections of Incidence and Mortality of Nasopharyngeal Carcinoma in China from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(34): 4269-4276. |
[4] | YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295. |
[5] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[6] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[7] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[8] | ZHANG Jifang, CHEN Fang, TANG Jiawen, LI Hongliang. Predictive Value of Tumor Budding and Tumor-infiltrating Lymphocytes on Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(32): 4038-4042. |
[9] | MA Liyuan, WANG Zengwu, FAN Jing, HU Shengshou. Interpretation of Report on Cardiovascular Health and Diseases in China 2022 [J]. Chinese General Practice, 2023, 26(32): 3975-3994. |
[10] | ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019. |
[11] | LI Yujing, JIN Yichao, CHEN Xing, JI Mengying, DAI Huihua. Risk Factors for Endometrial Lesions Detected by Hysteroscopy in Breast Cancer Patients Taking Tamoxifen [J]. Chinese General Practice, 2023, 26(32): 4026-4030. |
[12] | ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784. |
[13] | LI Jilei, LI Honglin, XU Yanchao, LIU Yanan, CHEN Mengli, SHAO Shuai, MA Chunzheng. Clinical Study on the Combination of Xiaotan Huayu Tongyi Granules, Channel Kaijie Pills and Chemotherapy in the Treatment of Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3759-3764. |
[14] | ZHENG Yuling, ZHANG Yaling, LIU Huaimin, XU Yanchao, JIA Xiaolin, LI Junsai, HE Wenlong, TONG Xinduo, QIN Shanwen, ZHANG Lihan. Clinical Observation of Dingxiang Guanshitong Hanhua Pills Alone and Its Combination with Fugui Guanshitong Granules in the Treatment of Advanced Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3765-3771. |
[15] | CHENG Jingwei, QIAO Junjun, YIN Zhen, HU Junpeng, WANG Qinghe, LIU Yangqing, WANG Yanfang. Interpretation of ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes [J]. Chinese General Practice, 2023, 26(30): 3719-3724. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||